When: Clean close above $111.25 on volume ≥10M with MACD histogram turning positive

Then: Consider adding back trimmed 15%; structural signal invalidates bearish setup

When: Q4 FY26 earnings clean beat with streaming OI margin ≥13%, parks operating margin guidance intact, FY27 capex reaffirmed ≤$8B

Then: Upgrade to Hold or Overweight on post-print weakness

When: Close below $101.41 on volume ≥10M (lower Bollinger Band breach)

Then: Full-position reassessment required; downgrade to SELL; exit remainder

When: Close below $99.50 on volume ≥10M

Then: Exit entire position regardless of any pre-commitment

Hold core position; trim maximum 10-15% only at $107 or above after clear rejection at 50 SMA and VWMA cluster; single reduction order (no tranches); $111.25 is re-evaluation trigger, not a stop

• Current price $103.61 is just $0.32 above 200-day SMA at $103.29 — a knife-edge support level
• ATR is $2.13; beta is 1.42; stock routinely moves $2/day on no news
• Aggressive analyst's $111.50 stop is too tight — $3.50 from upper entry at $108 gives zero room for volatility expansion in high-beta name
• Technical report explicitly says reasonable stop for shorts is ~$107.90 (2 ATRs above close), not $111.50
• Bollinger upper band has contracted from $112.94 to $108.38; ATR contracted from $2.47 to $2.13 — this is range-bound, not directional regime
• Technical report's own conclusion is HOLD with mean-reversion/range-trading favored over breakout trading
• Aggressive analyst's tranche approach (1/3 each at $106, $107, $108) likely results in partial fills and whipsaw in 7-dollar, 6-week range
• FY25 EPS surge was inflated by one-time tax benefit — FY26 operating fundamentals are strong on their own
• Valuation: PEG 3.33; forward P/E prices in 54% EPS growth, but FY26 operating metrics improving independently
• Q3 operating income up 30.5% YoY; operating margin expanded from 15.4% to 18.9%; EBITDA up ~11%
• Gross margin expanded from 34% in FY22 to ~38% in FY25 and still expanding
• Free cash flow grew from $1B to $10B+ in three years
• Buybacks accelerating: $3.5B in FY25, $3.5B in Q2 FY26, $1.75B in Q3; diluted share count down 5% in two years
• Conservative trim recommendation: max 10-15% at $107+ after resistance confirmation, single order not tranches
• $111.25 is re-evaluation trigger (not stop) — if price closes above on rising volume with MACD turning positive, bearish thesis is invalidated

→ vs aggressive: Stop at $111.50 is virtually guaranteed to be tagged by routine intraday volatility in a stock with beta 1.42 that just bounced $2.25 off a low in four sessions — crystallizing a loss AND requiring repurchase into stronger tape is worst possible outcome

→ vs aggressive: Tranche approach across a $2 range in a 6-week, $7-range stock is unlikely to fill completely; more likely outcome is partial fills at worst levels or whipsaw

→ vs aggressive: Using range-bound technicals (narrowed Bollinger Bands, contracted ATR) to justify a directional bet is inconsistent — size a range trade like a range trade, not a high-conviction directional move

→ vs aggressive: The asymmetric risk framing is one-directional: if wrong and stock rallies to $111-$117, the trim at $106-$108 must either be chased back or result in underperformance for months while thesis plays out

→ vs aggressive: Near-zero probability assigned to chop-higher-into-earnings scenario; Q1 FY27 earnings in November is a known catalyst that favors patience over pre-emptive aggressive reduction

→ vs aggressive: Strong fundamental improvements (margin expansion, FCF growth, accelerating buybacks) are being dismissed to simplify a bearish narrative when these metrics suggest earnings power is not structurally broken

Trim 15% at $106.50 on test of 50 SMA/VWMA cluster; retain 85% of position

• Current price $103.61, ATR $2.13, Beta 1.42
• Technical deterioration confirmed: MACD negative, 10 EMA collapsed, 200 SMA knife edge
• Aggressive's $111.50 stop is in the noise band (reasonable stop per technical report is ~$107.90)
• Proposed trim: 15% (not 30%) at $106.50, placed on test of 50 SMA and VWMA cluster rejection
• $111.25 is a structural re-evaluation trigger, not a hard market stop
• $101.41 is the line-in-the-sand support below which entire position must be reassessed
• This is a range trade with directional lean, not a pure directional short
• PEG ratio at 3.33 is rich; FY25 net income inflated by $7.5B tax one-time
• $1.7B in special charges is recurring drag, not one-time cleanup
• Q3 FY26 operating income up 30.5% YoY; EBITDA up ~11%
• Buybacks accelerating; share count down 5% in two years
• 10-year yields have 53% probability of hitting 5.5%
• Recession probability is 8% and falling; Fed on hold
• ATR down 14% from August; Bollinger Bands compressed
• Stock grinding sideways for six weeks; likely $101-$108 range for 3-5 weeks until November earnings
• Conservative's 'wait for confirmation' approach is late in compression setup

→ vs aggressive: $111.50 stop is too tight and sits in the middle of the noise band; a single headline or short covering squeeze gets the position stopped out at a loss while exposing remaining shares to higher prices

→ vs aggressive: 30% trim is too large for a range trade; the aggressive is treating this as a high conviction directional short when the dominant reality is a compressed range

→ vs conservative: 'Wait for confirmation at $107' is too late in a low volatility squeeze; by the time 50 SMA and VWMA reject cleanly, price is already at $104 and the next leg lower is in motion

→ vs conservative: Doing nothing is not the same as discipline; full hold while technicals deteriorate has real opportunity cost, drawdown cost, and psychological cost

→ vs conservative: $111.25 as 're-evaluation trigger' is a euphemism for no stop; without discipline at that level, it's the same problem in different form

→ vs conservative: Valuation argument overlooks Q3 operating income +30.5% YoY and EBITDA +~11%; the bounce off lows shows underlying earnings power is real